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The Postural Orthostatic Tachycardia Syndrome (POTS) is a condition in which heart rate
increases abnormally when the individual assumes an upright position. In addition to
the marked tachycardia, presyncope, and syncope, patients with POTS often complain
of light-headedness, fatigue, and difficulty in concentrating. The present study assessed
individuals with POTS for psychiatric comorbidity, anxiety sensitivity and health related
quality of life and examined general cognitive ability. Data was obtained from patients
with POTS (n = 15, 12 female, aged 30 ± 3 years) and age matched healthy subjects
(n = 30, 21 female, aged 32 ± 2 years). Patients with POTS commonly presented with
symptoms of depression, elevated anxiety and increased anxiety sensitivity, particularly
with regards to cardiac symptoms, and had a poorer health related quality of life in both
the physical and mental health domains. While patients with POTS performed worse
in tests of current intellectual functioning (verbal and non-verbal IQ) and in measures
of focused attention (digits forward) and short term memory (digits back), test results
were influenced largely by years of education and the underlying level of depression and
anxiety. Acute changes in cognitive performance in response to head up tilt were evident
in the POTS patients. From results obtained, it was concluded that participants with POTS
have an increased prevalence of depression and higher levels of anxiety. These underlying
symptoms impact on cognition in patients with POTS, particularly in the cognitive domains
of attention and short-term memory. Our results indicate that psychological interventions
may aid in recovery and facilitate uptake and adherence of other treatment modalities in
patients with POTS.
Keywords: orthostatic intolerance, tachycardia, psychiatric comorbidity, sympathetic nervous system,
noradrenaline transporter
INTRODUCTION
It is estimated that the lifetime cumulative incidence of syn-
cope is approximately 35% (Ganzeboom et al., 2006) and that
syncope-related hospitalizations cost the US healthcare system
upwards of $2.4 billion (Sun et al., 2005). While most forms
of orthostatic intolerance are associated with a reduction in
blood pressure upon standing, one specific condition, the pos-
tural orthostatic tachycardia syndrome (POTS), is characterized
by an excessive rise in heart rate (standing heart rate increases
by 30 beats or more per min or exceeding 120 beats/min) and
may be accompanied by presyncope or syncope in the absence
of postural hypotension (Low et al., 1995; Jacob et al., 2000).
The age of POTS patients is typically in the range 15–50 years,
with women more likely to develop the disorder than men (Low
et al., 1995). With research advances and growing physician
education the number of patients found to have POTS has been
rising.
In addition to the obvious cardiovascular-related symptoms,
patients with POTS may describe difficulty in concentration and
experiencing distraction and transient memory deficits which
intrudes on personal and work life. Orthostatic stress in patients
with chronic fatigue syndrome with POTS has been shown to be
associated with neurocognitive impairment (Ocon et al., 2012).
Repeated episodes of syncope may lead to distress and psychoso-
cial dysfunction, seriously interfering with quality of life, and
potentially increasing the incidence of mood or anxiety disorders.
The aim of the present study was to evaluate baseline psy-
chological and cognitive functioning in patients with POTS
and to examine whether individuals with POTS would exhibit
an increased latency of response time on cognitive tasks when
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changing from the supine to head up position when compared
with control participants.
MATERIALS AND METHODS
PARTICIPANTS
Patients with POTS (n = 15, 12 female, aged 30 ± 3 years) were
recruited from either the medical outpatient clinics of the Alfred
Hospital or the cardiovascular clinics at the Baker IDI Heart
& Diabetes Institute. Diagnosis of POTS was made using cri-
teria proposed by Low et al. (1995). Healthy subjects (n = 30,
21 female, aged 32 ± 2 years) were recruited from the gen-
eral community. All participants underwent a comprehensive
clinical and physical examination to screen for any previously
undiagnosed medical conditions prior to their acceptance in the
experimental protocols. Exclusion criteria included a history of
major illness, current drug medication and current or previous
use of psychotropic medication. The study was approved by The
Alfred Hospital and Monash University Human Research Ethics
Committees and all participants provided written, informed con-
sent for their participation.
PSYCHOLOGICAL EVALUATION AND COGNITIVE TESTING
All participants undertook a structured clinical interview in
order to examine psychiatric co morbidity. All interviews were
conducted by a trained psychologist. Evaluation included: Mini
International Neuropsychiatric Interview (MINI, Version 5.0.0)
(Sheehan et al., 1998); Hamilton depression and anxiety rating
scales (HAM-D and HAM-A respectively) (Hamilton, 1960). The
Anxiety Sensitivity Profile (ASP) was used to assess the patients’
belief that their bodily sensations have harmful consequences
(Taylor and Cox, 1998). The ASP is a 60-item expanded assess-
ment of anxiety sensitivity and was designed to evaluate six
relevant domains, although factor analytic studies suggest four
first-order factors tapping fears of (1) respiratory, (2) cognitive
dyscontrol, (3) gastrointestinal, and (4) cardiac symptoms. Each
question relates to the likelihood that particular sensations would
lead to something bad happening to the participant. Responses
were provided as a likert score ranging from 0 (not likely at all) to
7 (extremely likely).
A selection of cognitive measures was chosen to measure
intelligence and specific cognitive processes such as attention,
information processing and short term memory. The major mea-
sure for general intelligence was theWechsler Abbreviated Scale of
Intelligence (WASI) (Wechsler, 1999). In addition, scales from the
more comprehensiveWechsler Adult Intelligence Scale III (WAIS-
III) were employed (Weschler, 1997). For example, the digit span
subtest was included to examine attention and short-term mem-
ory. The digit span test is composed of two tasks administered
independently of each other, namely digits forwards and digits
backward. On both tasks the examiner read a series of num-
ber sequences to the examinee. For each digits forward item,
the examinee was required to repeat the number sequence in
the same order as presented. For digits backward the exami-
nee was required to repeat the number sequence in the reverse
order. Conceptually, the digit span subtest involves the audi-
tory perception of simple stimuli, working memory to integrate
and store information followed by simple vocal output of digits
retained. Scores on digit span were referenced against norma-
tive data based on the WAIS-III where a scaled score of 10 ± 2
standard deviations is considered within the bounds of normal.
COGNITIVE CHANGE IN RESPONSE TO HEAD-UP TILT
The CogState computer based test battery (Maruff et al., 2009),
comprising detection (attention), identification (information
processing), and learning (short termmemory) was used to assess
dynamic changes in cognitive performance in response to ortho-
static challenge. The detection task was used as a brief measure of
psychomotor function, information processing or speed of think-
ing. For this task the participant was presented with a playing card
face down at the center of the computer display. An on-screen
wizard helper prompted the participant to “Press YES as soon as
a card turns face up.” Thus, the participant would commence by
pressing the “Yes” key. After a delay, the card in the center would
then flip over so as to present face up.When this occurred the par-
ticipant would be required to press the “Yes” key. This sequence
was repeated multiple times, at randomly different intervals. The
primary outcome measure of the detection task was speed of per-
formance and the duration of the test was approximately 2min.
The identification task was employed as a measure of attention,
choice reaction time, and decision making. A playing card was
presented face down at the center of the computer display. The
on-screen wizard prompted the participant: “Is the face-up card
red?” The participant would respond by pressing the “Yes” key.
Following a delay, the card in the center would then flip over so
as to present face up. As soon as this occurred, the participant
would be required to decide whether or not the card presented
was red in color and subsequently indicate their choice by use
of the “Yes” or “No” key. The primary outcome measure of the
Identification task was speed and accuracy of this performance.
Time taken to complete the task at each level of tilt was approxi-
mately 2min. The One Card Learn test was used as a measure of
short-term memory. A playing card was presented to participants
face down at the center of the computer display. The on-screen
wizard prompted the participant: “Have you seen this card before
in this task?” They would then respond by pressing the “Yes” key.
The card in the center would flip over so as to present face up. As
soon as this occurred, the participant would then be required to
decide whether or not the same card had appeared face up before
in the task, and respond using the “Yes” or the “No” key (the first
answer given in a test was always “No”). The card would then go to
the back of the pack and after a random delay the next card would
be revealed. As soon as the next card was revealed, the partici-
pants would indicate whether or not the card had been seen before
in the task. The participant was required to attempt to recall all
the cards that had been shown previously in the task in order
to make a decision. Only some of the cards would repeat. Time
taken to complete this task at each level of tilt was approximately
5min.
Participants were familiarized with the testing program after
which testing was performed with participants in the semi recum-
bent position and after 8min of 60◦ head up tilt. Blood pres-
sure was monitored continuously using the Finometer system
(Finapress Medical System BV, Amsterdam, The Netherlands)
and heart rate was extracted from lead-III ECG. All of
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these parameters were digitized with a sampling frequency of
1000Hz (PowerLab recording system, model ML 785/8SP, ADI
Instruments). The double product, as an estimate of cardiac work,
was calculated as the product of heart rate and systolic blood
pressure.
QUALITY OF LIFE ASSESSMENT
The 36 Item Short-FormHealth Survey (SF-36) was used to assess
health related quality of life (Ware and Sherbourne, 1992). The
questionnaire contains 36 items that yield 8 category scales: phys-
ical functioning, role limitations caused by physical problems,
bodily pain, general health, vitality, social functioning, role lim-
itations caused by emotional problems, and mental health. Scale
scores range from 0 to 100, with higher scores indicating better
health. The 8 category scores can be aggregated into two summary
scales, the physical component summary scale and the mental
component summary scale. The SF-36 has demonstrated excel-
lent psychometric properties in both patient and healthy control
populations (Ware and Sherbourne, 1992).
STATISTICAL ANALYSIS
Statistical analysis was performed using Statistical Package for
the Social Sciences (SPSS) Version 22.0 (SPSS Inc., Chicago
USA). Group data are reported as mean ± standard error of
the mean. Comparisons between groups were performed using
a One Way ANOVA. Analysis was performed on ranks for non-
Gaussian data. The effects of head up tilt were assessed using
One Way ANOVA for repeated measures. Associations between
the variables were examined using Pearson product moment cor-
relation and stepwise multiple regression. A value of P < 0.05 was
considered significant.
RESULTS
PARTICIPANT DEMOGRAPHICS, DEPRESSION AND ANXIETY SCORES
The baseline clinical characteristics, years of education and
depression and anxiety scores of the patients with POTS and
the control subjects are presented in Table 1. The control group
was well matched for age, gender, and BMI. Patients with
POTS tended to have spent approximately 1½ less years in for-
mal education. Supine heart rate, blood pressure and, hence,
double product, were similar between groups. Clinician rated
Hamilton anxiety and depression ratings were significantly higher
in the POTS group. Thirteen of the subjects with POTS pre-
sented with current mild-moderate major depressive disorder
and one had a past history of panic disorder. In the con-
trol group one subject presented with symptoms of depres-
sion, with the severity being in the mild range (Ham-D 8-
13), and one subject had symptoms of generalized anxiety
disorder. There was no association between years of educa-
tion, Ham-D or Ham-A scores and resting heart rate or blood
pressure.
HEALTH RELATED QUALITY OF LIFE
Patients with POTS scored significantly worse in all of the eight
SF-36 domain scores (Figure 1, all P < 0.001). Consequently,
both the physical (52 ± 6 vs. 41 ± 7, P < 0.001) and mental
health (51 ± 8 vs. 39 ± 14, P < 0.001) component summary
Table 1 | Participant characteristics.
Control POTS P value
Age (years) 31.6±1.8 30.1±2.9 0.66
BMI (kg/m2) 25.6±0.7 24.6±1.1 0.45
Heart rate (b/min) 71±3 74±3 0.37
Blood pressure
(mmHg)
130±3/75 ± 2 132±5/75 ± 3 0.76/0.94
Double product
(mmHg.b/min)
9292±456 9849±669 0.52
Education (years) 14.6±0.6 12.9±0.6 0.05
Ham-A score 5±1 18±2 <0.001
Ham-D score 3±1 12±1 <0.001
scores were significantly diminished in the subjects with POTS.
There was no association between resting heart rate or blood
pressure and any of the SF-36 measures.
ANXIETY SENSITIVITY
Anxiety sensitivity is presented inTable 2. Participants with POTS
reported increased anxiety sensitivity in relation to cognitive
and cardiac symptoms, and dissociation (Table 2). The ASP Full
Scale score was significantly worse in the POTS patients. Anxiety
sensitivity was not quantitatively linked to heart rate or blood
pressure.
COGNITIVE FUNCTION
Neuropsychological assessment data in healthy subjects and
POTS participants are presented in Table 3. Univariate analysis
indicated that patients with POTS performed significantly worse
in all aspects examined. While performance in the cognitive tests
was not influenced by age or BMI there occurred strong asso-
ciations between test results and years of education (positive,
Table 3, all P < 0.01) and underlying level of depression and
anxiety (both negative, Table 3, all P < 0.01). Forward stepwise
regression analysis indicated that the verbal IQ test results could
be predicted by a combination of years of education (P = 0.02)
and Ham-A rating (P = 0.04), with the combination of these fac-
tors accounting for approximately 30% of the variance in the
verbal IQ test results (Table 4). Non-verbal (performance) IQ
could be predicted from years of education (P < 0.001). Full scale
IQ could be predicted by a combination of years of education
(P = 0.004) and Ham-A rating (P = 0.01), with these factors
accounting for 43% of the variance in the Full scale IQ test results
(Table 4). Performance in the digits forward and backwards tests
was influenced more by the underlying level of depression than
by years of education or anxiety. Digit span forward results could
be predicted by a combination of Ham-D score (P = 0.003) and
years of education (P = 0.02), with the combination of these fac-
tors accounting for 41% of the variance in digits forward scores.
Hamilton depression scores accounted for 27% of the variance
in digits backwards scores (P < 0.001). The overall Digit span
score could be predicted by a linear combination of Ham-D score
(P < 0.001) and years of education (P = 0.01), with the combi-
nation of these factors accounting for 46% of the variance in the
test score (Table 4).
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FIGURE 1 | Health related quality of life. Polar plot indicating SF-36 domain scores in patients with POTS () and in healthy subjects (•). Patients with POTS
scored significantly worse in all domains, P < 0.001, n = 30 control and 15 POTS.
Table 2 | Anxiety sensitivity profile (ASP) scores across multiple
domains of symptom anxiety sensitivity.
Control POTS P value
Cognitive 19±3 37±4 0.04
Cardiac 16±3 25±3 <0.001
Gastro 14±2 17±3 0.32
Respiratory 22±3 33±5 0.06
Humiliation 17±3 23±3 0.16
Dissociation 18±3 27±2 0.03
ASP full (/420) 107±15 158±17 0.02
COGNITIVE FUNCTION IN RESPONSE TO HEAD UP TILT
The change in heart rate in response to 60◦ head up tilt was
significantly greater in the POTS patients (11 ± 1 vs. 34 ±
3 b/min, P < 0.001, Figure 2). Similarly, the double product in
POTS patients increased substantially following head up tilt
(+890 ± 839 vs. +5139 ± 655mmHg.b/min, P = 0.008). There
was no difference in the blood pressure response during tilt testing
(141 ± 4/88 ± 3 in control vs. 136 ± 5/83 ± 4mmHg in POTS,
P = 0.58/0.43).
Acute changes in cognitive function, with recordings per-
formed in the semi recumbent position and at 60◦ head up tilt,
were examined in 26 of the control subjects and in 11 POTS
patients. In the semi recumbent position there were no differ-
ences between groups in attention (detection task response speed
332± 13 vs. 325± 15ms, Control vs. POTS, P = 0.76), informa-
tion processing (identification task processing speed 484 ± 19 vs.
538 ± 35ms, Control vs. POTS, P = 0.19) or short term mem-
ory (1055 ± 55 vs. 1064 ± 72ms, Control vs. POTS, P = 0.94,
Figure 3). Patients with POTS performed significantly worse than
the control subjects in the attention (detection) test during 60◦
head up tilt (Figure 3). Post-hoc analysis indicated that there was
a 15% improvement in performance time between supine and tilt
60◦ in healthy subjects (P < 0.05), and that there was a significant
worsening of performance in individuals with POTS, as indi-
cated by a 24% increase in latency of performance response times
between the semi recumbent position and tilt 60◦ (P < 0.05).
The change in detection task response time following tilt was
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Table 3 | Cognitive profile in healthy subjects and in patients with POTS.
Test Control POTS P value Education(Pearson r) Ham-D(Pearson r) Ham-A(Pearson r)
Verbal IQ (VIQ) 110±2 102±2 0.02 0.50 −0.46 −0.47
VIQ % 71±4 52±6 0.01 0.53 −0.52 −0.53
Non-verbal-IQ (NVIQ) 114±2 106±3 0.01 0.52 −0.42 −0.46
NV-IQ % 78±3 60±6 0.006 0.55 −0.44 −0.49
Full scale IQ (FSIQ) 114±2 33±5 0.003 0.58 −0.51 −0.56
FSIQ % 78±3 55±6 0.001 0.64 −0.58 −0.65
Digit span (forward) 11.0±0.4 8.9±0.4 0.001 0.55 −0.59 −0.56
Digit span (backward) 8.1±0.3 6.3±3 0.003 0.47 −0.53 −0.52
Digit span 19±1 15±1 0.001 0.57 −0.63 −0.60
Digits scaled score 11.2±0.4 8.9±0.6 0.001 0.51 −0.62 −0.62
Verbal IQ, verbal intelligence quotient; Non-verbal IQ, non-verbal intelligence quotient; Full Scale IQ, full scale intelligence quotient, Digit span presented as number
of digits recalled, scaled scores of WASI where population X = 10; IQ scores where population X = 100; % = percentile score relative to normative data of WASI.
Hamilton Depression rating (Ham-D), Hamilton Anxiety rating (Ham-A). Analyses controlled for age and gender.
Table 4 | Multivariate analysis of variables influencing cognitive test
results.
Test Variables β P
VERBAL IQ (VIQ)
Model 1 Education 0.50 <0.001
Model 2 Education 0.35 0.02
Ham-A −0.31 0.04
NON-VERBAL-IQ (NVIQ)
Model 1 Education 0.52 <0.001
FULL SCALE IQ (FSIQ)
Model 1 Education 0.58 <0.001
Model 2 Education 0.41 0.004
Ham-A −0.35 0.01
DIGIT SPAN (FORWARD)
Model 1 Ham-D −0.59 <0.001
Model 2 Ham-D −0.42 0.003
Education −0.34 0.02
DIGIT SPAN (BACKWARD)
Model 1 Ham-D −0.54 <0.001
DIGIT SPAN
Model 1 Ham-D −0.63 <0.001
Model 2 Ham-D −0.46 0.003
Education −0.34 0.01
Verbal IQ, verbal intelligence quotient; Non-verbal IQ, non-verbal intelligence
quotient; Full Scale IQ, full scale intelligence quotient, Digit span presented as
number of digits recalled. Other variables included in analysis: group (i.e., Control
vs. POTS), age and gender.
significantly associated with the change in heart rate (r = −0.51,
P = 0.004). In individuals with POTS there occurred a 13%
increase in response time between the semi recumbent position
and 60◦ head up tilt with the identification task, resulting in a 27%
difference in performance response times between both groups
at tilt 60◦. The change in identification task response time could
be predicted by a combination of full scale IQ (P < 0.001) and
the SF36 social (P = 0.007) and physical (P = 0.03) functioning
FIGURE 2 | Heart rate response during head up tilt. Graph showing heart
rate in the semi recumbent position and at 60◦ head up tilt in patients with
POTS () and in healthy subjects (•). ∗P < 0.05, n = 26 control and 11
POTS.
scores, with the combination of these factors accounting for 47%
of the variance in the change in identification task response time.
Performance in the one card learning task was not influenced
by tilt.
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FIGURE 3 | Cognitive testing during head up tilt. Bar graphs showing CogStat test results in the semi recumbent position and at 60◦ head up tilt in patients
with POTS and in healthy subjects. ∗P < 0.05, n = 26 control and 11 POTS. Black bars indicate patients with POTS and white bars indicate healthy subjects.
DISCUSSION
In this study we examined cognitive function in patients with
POTS, paying particular attention to the possible association
between cognitive performance and underlying symptoms of
depression and anxiety. Patients with POTS commonly presented
with symptoms of depression, elevated anxiety and increased anx-
iety sensitivity, and had a poorer subjective health related quality
of life in both the physical and mental health domains. While
patients with POTS performed worse in tests of current intellec-
tual functioning (verbal and non-verbal IQ) and in measures of
focused attention (digits forward) and short term memory (dig-
its back), test results were influenced largely by years of education
and the underlying level of depression and anxiety rather than the
categorical diagnosis of POTS. Acute changes in cognitive per-
formance in response to head up tilt were evident in the POTS
patients.
Patients with POTS experienced markedly diminished health-
related quality of life across both physical and mental health
domains. This observation is congruent with findings of a reduc-
tion in quality of life in the context of repeated episodes of
syncope (Linzer et al., 1991) and in those with chronic illness
(Lambert et al., 2012). It is recognized that the prevalence of
depression is elevated in patients with chronic, physical illnesses
such as heart disease, stroke, cancer, and diabetes mellitus (Clarke
and Currie, 2009). In line with this observation we found that
the majority of our POTS patients presented with symptoms of
major depressive disorder and had an elevated level of anxiety.
Raj and colleagues noted that, at the time of testing, patients with
POTS presented with symptoms of mild depression, although
life time prevalence of major depressive disorder was not ele-
vated (Raj et al., 2009b), and McGrady et al. found that subjects
who had a positive tilt table test for autonomic dysfunction had
higher depression scores (McGrady et al., 2001). Importantly, in
our study the increased level of depression and anxiety impacted
negatively on some aspects of cognitive function, in particular
attention and short-term memory. Depressive symptoms have
been associated with distractibility and impaired cognitive pro-
cessing, particularly in the context of higher cognitive abili-
ties such as executive processing, organization, and recall of
information. Our data is consistent with a previous report by Raj
et al. who demonstrated that patients with POTS scored worse
than controls on Connors Adult Attention Deficit Hyperactivity
Disorder (ADHD) inattention/memory problems subscale (Raj
et al., 2009b). It is likely that the association between depression
and cognitive performance reflects the underlying neurobiology
of depression, with alterations in brain monoamines influenc-
ing both depression and cognition (Lambert et al., 2000; Austin
et al., 2001; Schmitt et al., 2006; Barton et al., 2008; Wingen et al.,
2008; Chalermpalanupap et al., 2013). Noradrenaline transporter
(NET) dysfunction is evident in patients with POTS (Shannon
et al., 2000; Lambert et al., 2008) and in untreated patients with
major depressive disorder (Barton et al., 2007). Interestingly,
genetic variation in the NET gene has been associated with deficits
in memory and attention in patients with ADHD (Thakur et al.,
2012). Although coding mutations in the NET gene in POTS are
rare (Shannon et al., 2000) epigenetic modification of the NET
gene may impact NET expression in POTS (Bayles et al., 2012)
and perhaps influence learning and memory (Day and Sweatt,
2011).
An abnormality in neuronal noradrenaline reuptake
could sensitize the heart to sympathetic nervous activation.
Interestingly, given that POTS is more prevalent in females,
previous studies have noted differences in NET function between
genders. For instance, examination of the acute effects of selective
NET blockade with reboxetine indicated that NET function,
or expression, is reduced in women (Schroeder et al., 2004).
Moreover, female sex hormones influence the cardiovascular
response to NET inhibition in young women (Moldovanova
et al., 2008) and estrogen supplementation attenuates the sympa-
thetic and hemodynamic response to mental stress in both elderly
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men and perimenopausal women (Komesaroff et al., 1999, 2002).
An earlier report by Rosano et al. noted a reciprocal relationship
between female sex hormones and the incidence of paroxysmal
supraventricular tachycardias (SVT), with an inverse correlation
between plasma 17-β-estradiol and a positive association between
plasma progesterone and number of episodes and duration of
SVT (Rosano et al., 1996). Although muscle sympathetic activity
and the sensitivity of the sympathetic baroreflex vary throughout
the menstrual cycle in healthy subjects (Minson et al., 2000), Fu
et al. found that the plasma catecholamine response to standing
remained unchanged during the phase of the menstrual cycle
but noted an association between incidence of presyncope and
reduced plasma renin activity and aldosterone levels in the early
follicular phase of the menstrual cycle in patients with POTS (Fu
et al., 2010). Interestingly, changes in cognitive function during
the menstrual cycle have also been reported. Changes in estrogen
levels have been shown to be associated with improved verbal
working memory span (Rosenberg and Park, 2002), with effects
perhaps being controlled by prefrontal dopaminergic neuronal
activity (Jacobs and D’esposito, 2011). Although we found no
effect of gender on cognitive function, our sample size was
small and we did not take into account phase of the menstrual
cycle or the use of oral contraceptives in our investigation.
Whether cyclic variations in female sex hormones influenced the
results of the present study remains unknown but merits further
attention.
Given the distinctive feature of POTS, namely the marked
elevation in heart rate on standing, increased anxiety sensitiv-
ity, particularly in relation to cardiac features is perhaps not
surprising and is consistent with some (Benrud-Larson et al.,
2002, 2003), but not all (Raj et al., 2009b), previously reported
data. Individuals with disorders of postural syncope may be
more likely to focus attention on the negative consequences
of fainting; a preoccupation which subsequently contributes to
reduction in perceived health related quality of life (McGrady
et al., 2001). While physical symptoms are likely to be impor-
tant factors in reducing quality of life in POTS, our results
also indicate that heightened incidence and severity of psycho-
logical and cognitive factors may also play a role. Hyper vig-
ilance to somatic sensations and catastrophic cognitions have
been associated with greater limitations on day to day activi-
ties and increased perception of disability (Benrud-Larson et al.,
2003).
We found that patients with POTS experienced delays in
attention and information processing compared with the con-
trol subjects during head up tilt. This observation is consis-
tent with a recent report by Stewart et al. (2012) who exam-
ined cognitive performance in young chronic fatigue syndrome
patients with POTS. Perhaps underpinning the acute impair-
ment in cognitive performance, reduced cerebral blood flow and
a possible uncoupling of cerebral autoregulation during head
up tilt has been demonstrated in patients with POTS (Ocon
et al., 2009). Additionally, given that the reduction in cognitive
performance during the detection task was significantly asso-
ciated with the magnitude of the change in heart rate, and
that patients with POTS displayed significantly elevated anxi-
ety sensitivity in relation to cardiac symptoms, it is possible
that, in the context of increased vigilance to somatic sensa-
tions, attention is diverted and impaired cognitive performance
follows.
Treatment of POTS involves the implementation of a disease
management plan encompassing education, pharmacotherapy,
and exercise. Remaining hydrated, avoidance of excessive heat,
wearing compression tights in order to reduce venous pool-
ing, administration of fluid retaining agents, low dose propra-
nolol, acetylcoholinesterase inhibitors and exercise are all impor-
tant elements of the POTS treatment arsenal (Raj et al., 2005,
2009a; Fu et al., 2011; Shibata et al., 2012). Results from our
study point also to a possible benefit of psychological inter-
ventions. Techniques facilitating stress reduction and cognitive
behavior therapy, with an emphasis on identifying and restruc-
turing unhelpful beliefs, primarily those catastrophising con-
sequences of physical symptoms from standing, may aid in
recovery and facilitate uptake and adherence of other treatment
modalities.
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